Chronic cough: unmet needs, management and expert insights
Register for this live webinar on the impact, early diagnosis and management of chronic cough
Live: Wednesday 21 June 2023, 14:00 UTC
Join our live 60-minute EACCME and EBAP-accredited webinar for an expert faculty discussion on the unmet needs, impact and current management of chronic cough. The faculty highlight the importance of early diagnosis and existing therapeutic options for managing this condition following recent conceptual and clinical developments (agenda).
Live webinar agenda
|Chronic cough: unmet needs, management and expert insights
Date and time: Wednesday 21 June 2023, 14:00 UTC
|14:00||Welcome address||Professor Kian Fan Chung|
|14:05||Topic 1: Cough hypersensitivity, treatment options and unmet needs of chronic cough||Professor Kian Fan Chung|
|14:20||Topic 2: Pathways for early diagnosis of chronic cough||Associate Professor Marta Maria Dąbrowska|
|14:35||Topic 3: The physical, psychological, and social impact of chronic cough||Professor Alyn Morice|
|14:55||Closing remarks||Professor Kian Fan Chung|
Register now and join expert faculty for practical insights on the impact, diagnosis and management of chronic cough
After watching this webinar you should be able to:
- Identify the physical, psychological and social factors that impact the management of chronic cough
- Describe the challenges associated with the diagnostic pathways of chronic cough
- State the ERS guideline recommendations for the treatment of chronic cough
Professor Kian Fan Chung
Professor Kian Fan Chung MD, DSc is Professor of Respiratory Medicine and Head of Experimental Studies Medicine at the National Heart and Lung Institute, Imperial College London. He is a consultant respiratory physician at Royal Brompton and Harefield Hospitals, London. Professor Chung’s current interests are focused on the role of airway smooth muscle and the effects of oxidant stress on muscle function; on the energetics of airway smooth muscle function; and on the mechanisms underlying corticosteroid resistance. He has an interest in chronic cough, the cough hypersensitivity syndrome and in developing new treatments for this condition. Professor Chung is a senior investigator at the UK National Institute for Health Research and serves on the editorial boards of Respirology, Lancet Respiratory Medicine and the European Journal of Pharmacology.
Disclosures: Professor Chung reports receiving research grants through Imperial College from GSK on asthma and from Merck on chronic cough. He has participated in advisory board meetings for GSK, AstraZeneca, Novartis, Roche, Merck, Rickett-Beckinson, Nocion and Shionogi on asthma, chronic obstructive pulmonary disease (COPD) and chronic cough. He has undertaken speaking engagements for Sanofi, Novartis, AstraZeneca and Merck. He is on the Scientific Advisory Board of the Clean Breathing Institute supported by Haleon. He obtained educational support from Merck to his institution for the 12th London International Cough Symposium held in July 2022.
Associate Professor Marta Maria Dąbrowska
Professor Marta Maria Dąbrowska MD, PhD, DSc is Associate Professor at the Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland. Her research interests include the management of adults with chronic cough, chest imaging and bronchoscopy. Professor Dabrowska is a leader of the cough clinic in the Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, and is the Polish National Lead in NEUROCOUGH, European Respiratory Society (ERS) Clinical Research Collaboration.
Disclosures: Professor Dąbrowska has received consulting fees from MSD.
Professor Alyn Morice
Professor Alyn Hugh Morice MD, FRCP, FBPhS was appointed Foundation Chair, and Professor and Head of Respiratory Research Group, Hull York Medical School, University of Hull, UK in 1998. He has pioneered investigation into the epidemiology, diagnosis and therapeutics of cough, culminating in the production of national and ERS cough guidelines (ERJ 2020). His research on the neuronal mechanisms has improved our understanding leading to the concept of cough hypersensitivity, which has been translated by randomised controlled trials into therapeutic advances (opiates and P2X3 antagonists).
Disclosures: Professor Morice has received consulting fees from Bayer, Bellus, Merck, NeRRi and Shionogi; lecture fees from Boehringer Ingelheim, Merck and Chiesi; and grant support from Bayer, Bellus, Merck, Nocion, Philips, NeRRi and Shionogi.
are looking at
This content has been developed independently of the sponsor, Merck Sharp & Dohme, which has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.